• Policy
• Merck withdraws Tepmetko’s reimb application
• by Lee, Tak-Sun Apr 16, 2024 05:47am

• Policy
• K-pharma industry added 480 new jobs in Q4 of last year
• by Lee, Hye-Kyung Apr 16, 2024 05:47am

• Policy
• Will the COVID-19 drug Paxlovid be reimbursed in H1 2024?
• by Lee, Tak-Sun Apr 16, 2024 05:46am

• Policy
• Drugs with 'amlodipine' formulation get pediatric indication
• by Lee, Hye-Kyung Apr 15, 2024 06:06am

• Policy
• Reimb price of Forxiga generics fluctuates amid changes
• by Lee, Tak-Sun Apr 12, 2024 05:41am

• Policy
• Clopidogrel recall due to 1 CMO…’no issue escalation’
• by Lee, Hye-Kyung Apr 11, 2024 05:44am

• Policy
• 4th-generation, 3 chamber IV nutrition receives reimb
• by Lee, Tak-Sun Apr 11, 2024 05:44am

• Policy
• Approval of Beyfortus imminent in Korea
• by Lee, Hye-Kyung Apr 9, 2024 05:50am

• Policy
• 'Need patient engagement for reimb of high-priced drugs'
• by Lee, Tak-Sun Apr 8, 2024 05:46am

• Policy
• Recalls of antiplatelet drugs containing 'clopidogrel'…
• by Lee, Hye-Kyung Apr 5, 2024 05:44am